- All sections
- C - Chemistrymetallurgy
- C12R - Indexing scheme associated with subclasses , relating to microorganisms
- C12R 1/21 - Haemophilus
Patent holdings for IPC class C12R 1/21
Total number of patents in this class: 24
10-year publication summary
|
3
|
0
|
0
|
2
|
2
|
1
|
2
|
0
|
2
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Glaxosmithkline Biologicals S.A. | 1646 |
2 |
| King Abdulaziz University | 510 |
2 |
| Tsinghua University | 5922 |
1 |
| Bontac Bio-Engineering (Shenzhen) Co., Ltd | 72 |
1 |
| CapitalBio Corporation | 96 |
1 |
| Fundacao Oswaldo Cruz | 105 |
1 |
| Intercell AG | 20 |
1 |
| Intervet International B.V. | 1283 |
1 |
| Merial, Inc. | 220 |
1 |
| Newport Laboratories, Inc. | 6 |
1 |
| The Penn State Research Foundation | 1518 |
1 |
| Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences | 172 |
1 |
| Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences | 162 |
1 |
| Tianjin University | 802 |
1 |
| Universidade Estadual de Campinas - Unicamp | 274 |
1 |
| The University of Adelaide | 155 |
1 |
| Instituto Butantan | 33 |
1 |
| Boehringer Ingelheim Animal Health USA Inc. | 418 |
1 |
| Biocentury Transgene (China) Co., Ltd | 85 |
1 |
| Bontac Invitrolife Bio-technology (Shenzhen) Co., Ltd | 16 |
1 |
| Other owners | 2 |